252 related articles for article (PubMed ID: 23085026)
1. Differential effects of low-dose fenofibrate treatment in diabetic rats with early onset nephropathy and established nephropathy.
Kadian S; Mahadevan N; Balakumar P
Eur J Pharmacol; 2013 Jan; 698(1-3):388-96. PubMed ID: 23085026
[TBL] [Abstract][Full Text] [Related]
2. The low dose combination of fenofibrate and rosiglitazone halts the progression of diabetes-induced experimental nephropathy.
Arora MK; Reddy K; Balakumar P
Eur J Pharmacol; 2010 Jun; 636(1-3):137-44. PubMed ID: 20347778
[TBL] [Abstract][Full Text] [Related]
3. The combined strategy with PPARα agonism and AT₁ receptor antagonism is not superior relative to their individual treatment approach in preventing the induction of nephropathy in the diabetic rat.
Bishnoi HK; Mahadevan N; Balakumar P
Pharmacol Res; 2012 Oct; 66(4):349-56. PubMed ID: 22796657
[TBL] [Abstract][Full Text] [Related]
4. Fenofibrate and dipyridamole treatments in low-doses either alone or in combination blunted the development of nephropathy in diabetic rats.
Balakumar P; Varatharajan R; Nyo YH; Renushia R; Raaginey D; Oh AN; Akhtar SS; Rupeshkumar M; Sundram K; Dhanaraj SA
Pharmacol Res; 2014 Dec; 90():36-47. PubMed ID: 25263930
[TBL] [Abstract][Full Text] [Related]
5. Ameliorative effect of combination of benfotiamine and fenofibrate in diabetes-induced vascular endothelial dysfunction and nephropathy in the rat.
Balakumar P; Chakkarwar VA; Singh M
Mol Cell Biochem; 2009 Jan; 320(1-2):149-62. PubMed ID: 18830571
[TBL] [Abstract][Full Text] [Related]
6. Diltiazem attenuates oxidative stress in diabetic rats.
Anjaneyulu M; Chopra K
Ren Fail; 2005; 27(3):335-44. PubMed ID: 15957552
[TBL] [Abstract][Full Text] [Related]
7. Experimental diabetic nephropathy can be prevented by propolis: Effect on metabolic disturbances and renal oxidative parameters.
Abo-Salem OM; El-Edel RH; Harisa GE; El-Halawany N; Ghonaim MM
Pak J Pharm Sci; 2009 Apr; 22(2):205-10. PubMed ID: 19339234
[TBL] [Abstract][Full Text] [Related]
8. Taurine ameliorates alloxan-induced diabetic renal injury, oxidative stress-related signaling pathways and apoptosis in rats.
Das J; Sil PC
Amino Acids; 2012 Oct; 43(4):1509-23. PubMed ID: 22302365
[TBL] [Abstract][Full Text] [Related]
9. Amelioration of Diabetes-Induced Diabetic Nephropathy by Aloe vera: Implication of Oxidative Stress and Hyperlipidemia.
Arora MK; Sarup Y; Tomar R; Singh M; Kumar P
J Diet Suppl; 2019; 16(2):227-244. PubMed ID: 29621403
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic potential of (-)-epigallocatechin 3-O-gallate on renal damage in diabetic nephropathy model rats.
Yamabe N; Yokozawa T; Oya T; Kim M
J Pharmacol Exp Ther; 2006 Oct; 319(1):228-36. PubMed ID: 16835369
[TBL] [Abstract][Full Text] [Related]
11. Flavonoid rich fraction of Punica granatum improves early diabetic nephropathy by ameliorating proteinuria and disturbed glucose homeostasis in experimental animals.
Ankita P; Deepti B; Nilam M
Pharm Biol; 2015 Jan; 53(1):61-71. PubMed ID: 25289530
[TBL] [Abstract][Full Text] [Related]
12. Long-term treatment with Hachimi-jio-gan attenuates kidney damage in spontaneously diabetic WBN/Kob rats.
Nakagawa T; Yokozawa T; Yamabe N; Rhyn DY; Goto H; Shimada Y; Shibahara N
J Pharm Pharmacol; 2005 Sep; 57(9):1205-12. PubMed ID: 16105242
[TBL] [Abstract][Full Text] [Related]
13. Renoprotective Effects of Fenofibrate via Modulation of LKB1/AMPK mRNA Expression and Endothelial Dysfunction in a Rat Model of Diabetic Nephropathy.
Al-Rasheed NM; Al-Rasheed NM; Attia HA; Al-Amin MA; Al-Ajmi HN; Hasan IH; Mohamad RA; Sinjilawi NA
Pharmacology; 2015; 95(5-6):229-39. PubMed ID: 25967095
[TBL] [Abstract][Full Text] [Related]
14. Fenofibrate improves renal function by amelioration of NOX-4, IL-18, and p53 expression in an experimental model of diabetic nephropathy.
Yaribeygi H; Mohammadi MT; Rezaee R; Sahebkar A
J Cell Biochem; 2018 Sep; 119(9):7458-7469. PubMed ID: 29761900
[TBL] [Abstract][Full Text] [Related]
15. Quercetin, an anti-oxidant bioflavonoid, attenuates diabetic nephropathy in rats.
Anjaneyulu M; Chopra K
Clin Exp Pharmacol Physiol; 2004 Apr; 31(4):244-8. PubMed ID: 15053821
[TBL] [Abstract][Full Text] [Related]
16. A study on the effects to diabetic nephropathy of Hachimi-jio-gan in rats.
Yokozawa T; Yamabe N; Cho EJ; Nakagawa T; Oowada S
Nephron Exp Nephrol; 2004; 97(2):e38-48. PubMed ID: 15218322
[TBL] [Abstract][Full Text] [Related]
17. Trigonella foenum graecum seed extract protects kidney function and morphology in diabetic rats via its antioxidant activity.
Xue W; Lei J; Li X; Zhang R
Nutr Res; 2011 Jul; 31(7):555-62. PubMed ID: 21840472
[TBL] [Abstract][Full Text] [Related]
18. Renoprotective effect of lansoprazole in streptozotocin-induced diabetic nephropathy in wistar rats.
Kaur R; Sodhi RK; Aggarwal N; Kaur J; Jain UK
Naunyn Schmiedebergs Arch Pharmacol; 2016 Jan; 389(1):73-85. PubMed ID: 26475618
[TBL] [Abstract][Full Text] [Related]
19. Curcumin, the active principle of turmeric (Curcuma longa), ameliorates diabetic nephropathy in rats.
Sharma S; Kulkarni SK; Chopra K
Clin Exp Pharmacol Physiol; 2006 Oct; 33(10):940-5. PubMed ID: 17002671
[TBL] [Abstract][Full Text] [Related]
20. Polyphenolic extract of Ichnocarpus frutescens attenuates diabetic complications in streptozotocin-treated diabetic rats.
Kumarappan CT; Mandal SC
Ren Fail; 2008; 30(3):307-22. PubMed ID: 18350451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
